Ross Ward

8PUBLICATIONS

40CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityHaematological tumoursMedical molecular engineering of nucleic acids and proteins

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 10, 2026

Leveraging cDC1 biology and function for enhanced immunotherapy.

|Aug 05, 2025

Adsorption of antigen to polymeric nanoparticles enhances cytotoxic T-cell responses and anti-tumor immunity by targeting conventional type 1 dendritic cells.

Jorge Huete-Carrasco, Jingjing Zhu, Benoit J Van den Eynde

|Jul 27, 2025

The source of dietary fat influences anti-tumour immunity in obese mice.

Britta Kunkemoeller, Hannah Prendeville, Claire McIntyre

|Jan 22, 2025

Mitochondrial respiratory complex III sustains IL-10 production in activated macrophages and promotes tumor-mediated immune evasion.

Alessia Zotta, Juliana Toller-Kawahisa, Eva M Palsson-McDermott

|Nov 23, 2023

Rational design of polymer-based particulate vaccine adjuvants.

Jorge Huete-Carrasco, Roisin I Lynch, Ross W Ward

|Dec 16, 2022

Myeloid cell-derived proteases produce a proinflammatory form of IL-37 that signals via IL-36 receptor engagement.

Graeme P Sullivan, Pavel Davidovich, Natalia Muñoz-Wolf

Pageof 2

Frequent Collaborators

Ed C Lavelle

Jorge Huete-Carrasco

Graeme P Sullivan

Pavel Davidovich

Natalia Muñoz-Wolf

Yasmina E Hernandez Santana

Danielle M Clancy

Zaneta Najda

Boris Turk

Patrick T Walsh

Frequent Collaborators

Ed C Lavelle

Jorge Huete-Carrasco

Graeme P Sullivan

Pavel Davidovich